King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar spotpetes (< 20) Submitted: 8/13/2009 3:18:11 PM : Outperform Start Price: $10.57 KG Score: +3.45

Good looking company....

Report this Post Reply

Featured Broker Partners


Advertisement